Upstream Bio (UPB) Receivables - Other (2023 - 2025)

Upstream Bio has reported Receivables - Other over the past 3 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Receivables - Other at $1.7 million for Q4 2025, up 191.53% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (up 191.53% YoY), and the annual figure for FY2025 was $1.7 million, up 191.53%.
  • Receivables - Other for Q4 2025 was $1.7 million at Upstream Bio, up from $1.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for UPB hit a ceiling of $1.7 million in Q2 2025 and a floor of $138000.0 in Q4 2023.
  • Median Receivables - Other over the past 3 years was $1.2 million (2025), compared with a mean of $1.0 million.
  • Biggest five-year swings in Receivables - Other: soared 310.87% in 2024 and later surged 191.53% in 2025.
  • Upstream Bio's Receivables - Other stood at $138000.0 in 2023, then soared by 310.87% to $567000.0 in 2024, then surged by 191.53% to $1.7 million in 2025.
  • The last three reported values for Receivables - Other were $1.7 million (Q4 2025), $1.6 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.